ZORYVE (roflumilast) cream 0.3% is indicated for topical treatment of plaque psoriasis, including intertriginous areas, in patients 12 years of age and older. The use of ZORYVE is contraindicated in patients with moderate to severe liver impairment (Child-Pugh B or C)